National Institute of Health and Medical Research, Inserm
INSERM (Institut National de la Santé et de la Recherche Médicale) is the French National Institute of Health and Medical Research. It is a public research institution dedicated to biomedical and health research. INSERM plays a crucial role in advancing scientific knowledge and promoting healthcare innovation in France.
(Lille, FRANCE); co-PI; WP leader.
Amelie graduated as PhD from University of Lille in 2010. Her scientific career has been focused on the dissection of the genetic aetiologies of type 2 diabetes and obesity to elucidate their pathophysiology towards a better stratification of the patients and a putative identification of new drug targets. She is Director of Research (Inserm) and heads a team tackling “Metabolic functional (epi)genomics and their abnormalities in type 2 diabetes and related disorders”. She is also the current scientific director of the PIA-funded EquipEx LIGAN-PM platform dedicated to the use of next-generation sequencing in precision medicine. She has published >150 peer-reviewed scientific papers (H Index: 59 [Google Scholar]).
(Lille, FRANCE); co-PI; WP leader; Philippe is a renowned geneticist known for his contributions to the field of diabetes research. He has made significant discoveries in the genetic basis of obesity and type 2 diabetes. Philippe has identified several gene variants associated with these conditions, shedding light on their underlying mechanisms. He has published extensively, received numerous awards, and held prestigious academic positions. His research has paved the way for personalized medicine approaches in diabetes and obesity, offering insights into prevention, diagnosis, and treatment strategies. He has published >800 peer-reviewed scientific papers (H Index: 184 [Google Scholar]).